Chemed Corp. (CHE) fundamentals: P/E, valuation, undervalued?
Chemed Corp. · Health Care · ref. ETF XLV · price $500.77
In short — Chemed Corp. trades at 25.2× earnings (P/E), 18.2× forward, with a net margin of 10.6 % and revenue growth of +9 %. Read: Cheap for the growth (P/E 18 for ~44% growth (PEG 0.4)).
Is Chemed Corp. stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$500.77+14.6% over range
Oct 14, 25low $368.59 · high $552.72Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 4 analysts
Valuation : Cheap for the growth — P/E 18 for ~44% growth (PEG 0.4)
Valuation
25.2
P/E (price/earnings)
18.2
Forward P/E
0.58
PEG
7.8
Price/book (P/B)
$6.5B
Market cap
19.88
EPS
Profitability & growth
10.6 %
Net margin
+9 %
Revenue growth
+44 %
Earnings growth
$295M
Total debt
Chemed Corp. income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $2.1B | $250M | 11.7 % |
| 2023 | $2.3B | $273M | 12.0 % |
| 2024 | $2.4B | $302M | 12.4 % |
| 2025 | $2.5B | $265M | 10.5 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Chemed Corp.'s P/E and is the stock undervalued? What's a good P/E?
Chemed Corp.'s P/E is 25.2 (forward 18.2). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Chemed Corp. profitable?
Chemed Corp. has a net margin of 10.6 % (EPS 19.88). The company is profitable.
Is CHE stock expensive?
Our read: "Cheap for the growth" — P/E 18 for ~44% growth (PEG 0.4). Cross-check with growth and sector.
💬 A question about Chemed Corp.? The JPI assistant answers using our backtest data.
Keep exploring Chemed Corp.